4-MPD | |
---|---|
Molecular structure via molpic based on CDK |
Conformer [] | |
---|---|
Physical properties [] | |
---|---|
Molecular mass | 205.30 g/mol [1] |
Predicted LogP | 2.9 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C13H19NO [1] |
IUPAC name | 2-(methylamino)-1-(4-methylphenyl)pentan-1-one [1] |
SMILES | CCCC(C(=O)C1=CC=C(C=C1)C)NC [1] |
InChI | InChI=1S/C13H19NO/c1-4-5-12(14-3)13(15)11-8-6-10(2)7-9-11/h6-9,12,14H,4-5H2,1-3H3 [1] |
InChIKey | AKVKBEDACKJNPO-UHFFFAOYSA-N [1] |
4-Methylpentedrone
4-Methylpentedrone (also known as 4-MPD, 4-Methyl-α-methylamino-valerophenone, 1-Pentanone, 2-(methylamino)-1-(4-methylphenyl)-, 1-(4-Methylphenyl)-2-methylamino-pentan-1-one, YEC91861, 2-(methylamino)-1-(p-tolyl)pentan-1-one or 1-(4-methylphenyl)-2-(methylamino)pentan-1-one) is a
Chemistry
Stereochemistry []
4-Methylpentedrone is a racemic mixture of the enantiomers
Stereoisomers |
---|
Anodyne Usernotes [] | |
---|---|
0xea / 4-Methylpentedrone[hydrochloride] via Insufflated and Intravenous | Moderately Entactogenic; intense short acting Euphoria; quite potent; Stimulation lasting 2-3 hours intravenous |
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 124201807, 4-Methylpentedrone. Accessed July 14, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/124201807
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. 4-Methylpentedrone. UNII: G83HJ935NV. Global Substance Registration System. Accessed July 14, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/G83HJ935NV